Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB

Area of Science:

• Microbiology and Immunology
• Molecular Biology
• Toxinology

Background:

• Clostridium difficile infection (CDI) is a significant cause of hospital-associated diarrhea.
• CDI pathogenesis is primarily mediated by TcdA and TcdB toxins.
• TcdB toxin undergoes conformational changes during cellular intoxication.

Purpose of the Study:

• To investigate the role of a specific region (amino acids 1753-1851) of TcdB in toxin activity.
• To identify and characterize peptide inhibitors targeting TcdB.
• To explore novel therapeutic strategies for CDI by inhibiting TcdB function.

Main Methods:

• Peptide synthesis and derivation from the TcdB 1769-1779 region.
• Analysis of peptide interactions with TcdB carboxy-terminal domain.
• Assessment of TcdB structural destabilization and cell binding disruption.
• Investigation of PepB2 polymerization and its role in TcdB inhibition.

Main Results:

• Peptides, including PepB2, derived from TcdB region 1769-1779 protect cells from TcdB-mediated cytotoxicity.
• PepB2 destabilizes TcdB structure and inhibits its binding to host cells.
• PepB2 requires formation of a higher-order polymeric complex, facilitated by the central GN amino acid pair, for its inhibitory effects.

Conclusions:

• TcdB peptides can interact with the toxin's CROP domain to alter its conformation.
• Peptide-based inhibitors can effectively inactivate TcdB, a critical virulence factor.
• This study presents a novel approach for developing treatments to ameliorate CDI.